BioForm Medical Overview
- Year Founded
-
1999
- Status
-
Acquired/Merged
- Employees
-
310
- Latest Deal Type
-
M&A
- Financing Rounds
-
7
- Investments
-
1
BioForm Medical General Information
Description
Provider of medical aesthetics and products that are used by physicians to enhance a patient's appearance. The company offers Radiesse aesthetic, an injectable dermal filler used to provide aesthetic improvement for patients; Radiesse Voice and Radiesse Voice Gel for vocal fold insufficiency; and Coaptite injectable implant used as a bulking agent to treat women, who have stress urinary incontinence due to poorly functioning urethral sphincter muscles. It also provides licensed Aethoxysklerol agent, an injectable sclerosing drug for the treatment of varicose veins; BioGlue surgical adhesive for facial aesthetic applications; and RADIESSE dermal filler for subdermal implantation for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds, as well as for the restoration and/or correction of the signs of facial fat loss (lipoatrophy) in people with human immunodeficiency virus.
Contact Information
Corporate Office
- 1875 South Grant Street
- Suite 110
- San Mateo, CA 94402
- United States
Corporate Office
- 1875 South Grant Street
- Suite 110
- San Mateo, CA 94402
- United States
BioForm Medical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
BioForm Medical Patents
BioForm Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20180313787-A1 | Isolation of circulating tumor cells using electric fields | Inactive | 28-Apr-2017 | ||
| WO-2018200911-A1 | Isolation of circulating tumor cells using electric fields | Inactive | 28-Apr-2017 | ||
| WO-2008088381-A2 | Implantation compositions for use in tissue augmentation | Inactive | 08-Jan-2007 | ||
| WO-2008088381-A3 | Implantation compositions for use in tissue augmentation | Inactive | 08-Jan-2007 | ||
| US-20070184087-A1 | Polysaccharide compositions for use in tissue augmentation | Inactive | 06-Feb-2006 | A61L27/20 |
BioForm Medical Signals
BioForm Medical Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
BioForm Medical Acquisitions (1)
BioForm Medical’s most recent deal was a Merger/Acquisition with Aci Surgery for . The deal was made on 30-Apr-2008.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Aci Surgery | 30-Apr-2008 | Merger/Acquisition | Surgical Devices |
BioForm Medical FAQs
-
When was BioForm Medical founded?
BioForm Medical was founded in 1999.
-
Where is BioForm Medical headquartered?
BioForm Medical is headquartered in San Mateo, CA.
-
What is the size of BioForm Medical?
BioForm Medical has 310 total employees.
-
What industry is BioForm Medical in?
BioForm Medical’s primary industry is Surgical Devices.
-
Is BioForm Medical a private or public company?
BioForm Medical is a Private company.
-
What is the current valuation of BioForm Medical?
The current valuation of BioForm Medical is .
-
What is BioForm Medical’s current revenue?
The current revenue for BioForm Medical is .
-
How much funding has BioForm Medical raised over time?
BioForm Medical has raised $108M.
-
Who are BioForm Medical’s investors?
Carruthers Dermatology Centre, EW Healthcare Partners, Kenson Ventures, PTV Healthcare Capital, and Teknoinvest are 5 of 8 investors who have invested in BioForm Medical.
-
When was BioForm Medical acquired?
BioForm Medical was acquired on 16-Feb-2010.
-
Who acquired BioForm Medical?
BioForm Medical was acquired by Merz Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process